Advisory services for the dealmaking professional
Strengthen your negotiating position with expert analysis on biopharma deals. Recap analysts mine their extensive deals expertise to run the optimal comparables by therapy areas, indications, drug classes, and specific companies. With Recap on your side, you can get a better deal done faster.
Asset Valuation Services help you:
- Develop and implement strategic partnering plans
- Supplement resources for specific licensing opportunities or business development strategies
- Align perspectives from a neutral position
Make a better deal, faster, with Recap on your team.
Meet the Recap Advisory Team
Laura Vitez has over 25 years of experience in the life sciences industry. She has held lead and advisory business development roles at companies including multiple small biotechs, a mid-sized pharma, and two consulting firms. Ms. Vitez has participated in alliances generating more than $2 billion in reported value for her clients and companies. She holds an MS in Biochemistry and a BA in Mathematics and Chemistry. She joined Thomson Reuters Recap as a Principal Business Analyst in the fall of 2013.